Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Flu Vaccines
Fraunhofer USA Center for Molecular Biotechnology Receives Gates Foundation Grant for Avian Influenza Vaccine Development
February 18th, 2009
The Center for Molecular Biology (CMB) has received an $8.7 million grant from the Bill & Melinda Gates Foundation to support continued development of an avian influenza vaccine that uses transient plant-based technology. CMB will develop vaccines against highly pathogenic avian influenza viruses of H5N1 subtype, and work to advance promising candidates into clinical trials. Dr. Vidadi Yusibov, CMB's Executive Director said, "CMB's vaccine technology has the potential to revolutionize how vaccines are manufactured, allowing for a more rapid and affordable response to pandemic flu threats." "It is essential that new vaccines reach the people who need...
Source: Vaccine Weekly (2009-02-18)
|
